Form 4: Neogen Corp Director Jeffrey D Capello Reports Acquisition and Disposal of Securities
SEC Form 4 Filing
Director Jeffrey D Capello reports acquiring and disposing of Neogen Corp securities, including restricted stock units and common stock options, on October 24, 2024.
Summary
- On October 24, 2024, Jeffrey D Capello, a director of Neogen Corp, reported transactions involving the company's securities.
- Capello acquired 6,075 restricted stock units (RSUs) at a price of $13.58.
- He also acquired 18,653 options to buy common stock at an exercise price of $13.58, expiring on 10/24/2031.
- Additionally, Capello disposed of 18,653 derivative securities.
- Following these transactions, Capello beneficially owns 15,840 shares.
- The options and RSUs vest in equal annual installments over three years from the grant date.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider transactions. The acquisition of RSUs and options is mildly positive, while the disposal of derivative securities is mildly negative, balancing out overall.
Positives
- The acquisition of RSUs and options by a director signals confidence in the company's future performance.
Negatives
- The disposal of derivative securities could be interpreted negatively, but without further context, it's difficult to assess the reason.
Risks
- The vesting schedule of the RSUs and options could influence the director's decisions over the next three years.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may view the director's transactions as a signal of confidence or concern, depending on their interpretation of the acquisitions and disposals.
Key Dates
| Date | Description |
|---|---|
| 10/24/2024 | Date of securities transactions (acquisition and disposal of RSUs and options). |
| 10/24/2031 | Expiration date of the acquired common stock options. |
| 10/28/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.